Webcast: The Emerging Biosimilars Market
Monday, June 20, 2016
With biosimilar biological products moving from the lab to the marketplace, key policy and regulatory questions are being actively debated, with important implications for industry, patients, and the health care system. Our panel discussion provides background on current policy and regulatory issues surrounding these medicines.
Click this link to view the webcast: